Dow Rockets 150+ in Volatile Session
Stocks wavered on Thursday after President Donald Trump reiterated his tariff threats.The Dow Jones Industrials perked 168.61 points to 44,882.13.The much-broader index gained 31.86 points to 6,071.17. The NASDAQ Composite finished in the green 49.43 points to 19,681.75. The S&P 500 and tech-heavy NASDAQ Composite are on pace to end the week in negative territory, despite making up some of their losses from Monday’s selloff. The blue-chip Dow is the only major index tracking for a weekly gain. Stocks cut gains late in the session after President Donald Trump announced his intention to implement 25% tariffs on goods imported from Canada and Mexico.Shares of Meta Platforms accumulated 1% and Tesla added 3%, while Microsoft shares dipped 6% after the companies reported earnings. Meta beat on top and bottom lines, but Microsoft shares faltered after the company’s quarterly revenue forecast disappointed. Tesla shrugged off earnings and revenue misses.Other “Magnificent Seven” names are set to report in the coming days, with Apple’s results being due for a Thursday release. Amazon will soon follow suit, as the megacap tech company reports next week.On the other hand, investors were a bit cautious to buy after fourth-quarter GDP growth came in at just 2.3%, missing expectations.Prices for the 10-year Treasury vaulted, lowering yields to 4.52% from Wednesday’s 4.55%. Treasury prices and yields move in opposite directions.Oil prices gained 25 cents to $72.87 U.S. a barrel. Prices for gold brightened $53.60 an ounce to $2,847.10 U.S.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


